Inventor
CARRERAS CHRISTOPHER
US27 patents
⚠️ This page may combine multiple inventors who share the name “CARRERAS CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARDELYX INC
19 patentsUS10272079B2Apr 30, 2019
NHE3-binding compounds and methods for inhibiting phosphate transport
ARDELYX INC5 citations83
US9408840B2Aug 9, 2016
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
ARDELYX INC6 citations83
US8916569B2Dec 23, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8815910B2Aug 26, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8815908B2Aug 26, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8809339B2Aug 19, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC8 citations83
US11318129B2May 3, 2022
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC1 citations72
US10543207B2Jan 28, 2020
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations72
US10385024B2Aug 20, 2019
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations72
US10376481B2Aug 13, 2019
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations71
US10940146B2Mar 9, 2021
NHE3-binding compounds and methods for inhibiting phosphate transport
ARDELYX INC1 citations62
US9006281B2Apr 14, 2015
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC1 citations62
US8969377B2Mar 3, 2015
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations62
US12016856B2Jun 25, 2024
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC0 citations61
US11813304B2Nov 14, 2023
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations61
US9301951B2Apr 5, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9289430B2Mar 22, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9289429B2Mar 22, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9278102B2Mar 8, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
KOSAN BIOSCIENCES INC
5 patentsUS6562795B2May 13, 2003
Motilide compounds
KOSAN BIOSCIENCES INC34 citations91
US7211568B2May 1, 2007
9-Desoxoerythromycin compounds as prokinetic agents
KOSAN BIOSCIENCES INC17 citations84
US6946482B2Sep 20, 2005
Motilide compounds
KOSAN BIOSCIENCES INC10 citations73
US6750205B2Jun 15, 2004
Motilide compounds
KOSAN BIOSCIENCES INC11 citations72
US6875576B2Apr 5, 2005
Method for evaluating therapeutic efficacy
KOSAN BIOSCIENCES INC11 citations66